Xiaoyuan Chen, Ph.D., Chief of the Laboratory of Molecular Imaging and Nanomedicine at NIBIB, and his team attempted to solve this problem by
developing a radiotracer that could identify prostate cancer at all stages.
Not exact matches
Researchers at the National Institute of Biomedical Imaging and Bioengineering (NIBIB) have
developed a new
radiotracer to diagnose prostate cancer and conducted a successful Phase I clinical trial.
Brookhaven scientist Joanna Fowler describes Positron Emission Technology (PET) research at BNL which for the past 30 years has focused in the integration of basic research in
radiotracer chemistry with the tools of neuroscience to
develop new scientific tools for applications in human health.